Week 9 — Cell-Free Protein Synthesis

General Homework Questions

1. Advantages of Cell-Free Protein Synthesis

Cell-free protein synthesis offers several advantages over in vivo expression:

  1. Speed — no transformation, culture growth, or induction cycle. Protein can be expressed in hours rather than days or weeks.
  2. Open system / debuggability — with no cell wall in the way, you can directly add, remove, or adjust components mid-reaction. Troubleshooting is hands-on: swap the energy system, add chaperones, tweak Mg²⁺ — all in real time.
  3. Biosafety — no live GMOs means no antibiotic resistance cassettes spreading in the environment and a lower containment burden overall.
  4. Toxic proteins — proteins that would kill a host cell can be expressed freely in lysate.
  5. Non-natural amino acids — easier to incorporate than in living cells where the genetic code is fixed.

Two use cases where cell-free is preferred:

  • Biosafety-sensitive contexts — e.g. designing and testing antimicrobial peptides or toxins without engineering live bacteria that carry resistance genes.
  • Rapid prototyping — throughput per reaction is lower than in vivo, but the cycle time collapses from weeks to hours. Testing whether a protein variant folds or a genetic circuit fires becomes feasible at a pace that in vivo expression simply can’t match.

2. Components of a Cell-Free Expression System

A cell-free system is best understood as a build-your-own PC versus a sealed Mac. A living cell is like a Mac — you can give it inputs and read outputs, but everything happens inside a locked enclosure you can’t open. Cell-free lysate cracks that enclosure open and lays all the components on the table, letting you tinker directly with the machinery.

The key components and their roles:

  • Cell lysate — the burst contents of E. coli cells; contains all the hardware needed for transcription and translation: ribosomes, tRNA, elongation factors, RNA polymerase, and chaperones. This is the motherboard everything else plugs into.
  • DNA template — the software. Can be circular (plasmid) or linear (PCR product) — unlike in vivo expression, you don’t need to clone into a vector first. Swap in a different sequence and you get a different protein from the same hardware.
  • NTPs (ATP, GTP, CTP, UTP) — nucleotide building blocks for transcribing the DNA into mRNA.
  • Amino acids — the raw materials for translating mRNA into protein; all 20 must be present.
  • Energy regeneration system — keeps refuelling ATP as it gets consumed. Like a car that needs a continuous fuel supply, not a single tank fill: phosphoenolpyruvate (PEP) donates phosphate to ADP → ATP continuously throughout the reaction.
  • Mg²⁺ and K⁺ salts — ionic environment that ribosomes and polymerases require to function correctly.
  • Buffer (HEPES) — maintains stable pH so enzymes don’t denature mid-reaction.
  • RNase inhibitors — protect the mRNA from degradation so translation can proceed.

3. Energy Provision and ATP Regeneration

In progress.

4. Prokaryotic vs. Eukaryotic Cell-Free Systems

The choice between prokaryotic and eukaryotic lysate comes down to what protein you’re making and how much of it you need.

E. coli is a single-cell organism — no coordination overhead, no compartments to worry about. Prokaryotic lysate is cheaper and faster to prepare, and because each reaction is essentially independent, you can scale simply by running more reactions in parallel. It’s the right choice for enzymes, screening, and proteins that don’t require eukaryotic post-translational modifications.

Mammalian proteins are a different story. They evolved in a coordinated multi-system environment — glycosylation, signal peptides, disulfide bond formation — and a prokaryotic lysate lacks the machinery to faithfully reproduce that. If you’re targeting a protein that will eventually work in a mammalian context, you should express it in a mammalian (or at minimum eukaryotic) lysate from the start: wheat germ, rabbit reticulocyte, or HeLa-derived extracts. The trade-off is cost and complexity — eukaryotic systems are harder to prepare and less scalable — but for proteins that require correct folding and modification, there’s no shortcut.

Example: GFP or a simple enzyme → E. coli lysate. A glycosylated cytokine like erythropoietin (EPO) → mammalian lysate.

5. Optimizing Cell-Free Expression of a Membrane Protein

In progress.

6. Troubleshooting Low Yield

Three failure modes cover most low-yield scenarios:

  1. Insufficient energy — translation is expensive: every peptide bond costs ~4 ATP. If the energy regeneration system runs dry mid-reaction, the ribosome stalls. Think of it like a car that stops not because the engine is broken but because the fuel ran out. Fix: switch from PEP to a longer-lasting energy source like maltodextrin, which can sustain reactions for over 12 hours.

  2. mRNA degradation (signal integrity loss) — in a cell, mRNA is protected and chaperoned along optimal pathways. Outside that enclosure, RNases in the lysate chew up the transcript before translation can complete. The signal exists at the start but loses integrity before it reaches the output — like a message sent over a noisy channel with too much resistance. Fix: add RNase inhibitors to the reaction and use 5’ UTR sequences known to stabilize mRNA.

  3. Protein misfolding and aggregation — without the cell’s full complement of chaperones guiding co-translational folding, hydrophobic domains that should be buried can stick to each other and aggregate. The protein is produced but can’t be separated into a usable form — it precipitates out of solution. Fix: supplement with chaperones (GroEL/GroES, DnaK), lower the reaction temperature to slow folding kinetics, and reduce Mg²⁺ concentration.

Kate Adamala: Design a Synthetic Minimal Cell

In progress.

Function chosen: In progress.

Membrane composition: In progress.

Encapsulated components: In progress.

Tx/Tl system: In progress.

Measurement: In progress.

Peter Nguyen: Cell-Free Materials Application

In progress.

Domain: In progress.

Pitch: In progress.

Ally Huang: Genes in Space Proposal

In progress.